NOVA MENTIS LIFE SCIENCE CORP News

Psyched: LSD For Major Depression, Canada's Large Scale Psilocybin Macrodose Trial, Treatments For Autism Spectrum Disorder And Multiple Sclerosis And More

BenzingaApr 24, 2023 15:58 ET

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism

BenzingaApr 20, 2023 09:04 ET

Health Canada Grants Section 56 Exemption: Phase 2 Trial On Psilocybin For Leading Autism Cause

Benzinga Real-time NewsFeb 14, 2023 13:37 ET

Nova Mentis Life Science Appoints Executive Chairman

Seeking AlphaJan 18, 2023 08:56 ET

First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval

Benzinga Real-time NewsDec 27, 2022 12:48 ET

Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial

Benzinga Real-time NewsNov 30, 2022 13:01 ET

Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial

Benzinga Real-time NewsNov 17, 2022 14:52 ET

Magic Mushroom In A Pill? New Microdose Plans Enter Clinical Studies: Here's What Scientists Want To Learn

Benzinga Real-time NewsSep 29, 2022 14:36 ET

New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details

Benzinga Real-time NewsSep 17, 2022 18:06 ET

More Patent Applications For Psilocybin: Learn About NOVA's Psychedelic Treatments For Neurological Diseases

Benzinga Real-time NewsJun 16, 2022 13:40 ET

Nova Mentis NM-1001 Psilocybin Compound Gets DEA Approval For Export, Here's What Happened

Benzinga Real-time NewsJun 7, 2022 15:38 ET

Nova Mentis gets required U.S. DEA export approval for its psilocybin drug NM-1001

Seeking AlphaJun 7, 2022 09:42 ET

Nova Mentis Is Looking To Treat Autism With Psilocybin

Benzinga Real-time NewsApr 7, 2022 14:46 ET

This Psychedelics Penny Stock Is Up 55% After Successful Study On Microdosing For Autism

Benzinga Real-time NewsFeb 16, 2022 17:42 ET

Nova Mentis names new CFO

Seeking AlphaDec 31, 2021 09:04 ET

BRIEF-Nova Mentis Files Genetic Neuroinflammatory Disease Patent

reutersNov 9, 2021 09:16 ET

Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval

Benzinga Real-time NewsNov 8, 2021 10:54 ET

U.S. FDA Approves Nova Mentis Orphan Drug Application

MT NewswiresNov 2, 2021 10:54 ET

Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?

Benzinga Real-time NewsNov 1, 2021 16:38 ET

Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation

Benzinga Real-time NewsNov 1, 2021 12:40 ET